留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

低分化甲状腺癌的临床病理

孙健 李文波 杨堤 成殷 崔全才

孙健, 李文波, 杨堤, 成殷, 崔全才. 低分化甲状腺癌的临床病理[J]. 协和医学杂志, 2012, 3(1): 72-76. doi: 10.3969/j.issn.1674-9081.2012.01.016
引用本文: 孙健, 李文波, 杨堤, 成殷, 崔全才. 低分化甲状腺癌的临床病理[J]. 协和医学杂志, 2012, 3(1): 72-76. doi: 10.3969/j.issn.1674-9081.2012.01.016
Jian SUN, Wen-bo LI, Di YANG, Yin CHENG, Quan-cai CUI. Clinicopathological Characteristics of Poorly Differentiated Thyroid Carcinoma[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(1): 72-76. doi: 10.3969/j.issn.1674-9081.2012.01.016
Citation: Jian SUN, Wen-bo LI, Di YANG, Yin CHENG, Quan-cai CUI. Clinicopathological Characteristics of Poorly Differentiated Thyroid Carcinoma[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(1): 72-76. doi: 10.3969/j.issn.1674-9081.2012.01.016

低分化甲状腺癌的临床病理

doi: 10.3969/j.issn.1674-9081.2012.01.016
详细信息
    通讯作者:

    崔全才 电话:010-65295520, Email:cuiqc@sina.com

  • 中图分类号: R736.1;R446.8

Clinicopathological Characteristics of Poorly Differentiated Thyroid Carcinoma

More Information
    Corresponding author: CUI Quan-cai Tel: 010-65295520, Email:cuiqc@sina.com
  • 摘要:   目的  观察低分化甲状腺癌(poorly differentiated thyroid carcinoma, PDTC)的临床病理特点。  方法  回顾性分析北京协和医院12例符合都灵诊断共识的PDTC临床、影像和病理学资料, 并采用EnVision法进行免疫组织化学标记。  结果  12例PDTC病例中11例为女性, 1例为男性, 平均发病年龄53.6岁。临床均表现为前颈部肿块, B超示肿物为低回声实性结节。5例患者肿瘤主要呈粱状生长, 4例主要呈岛状生长, 3例主要呈实性生长。免疫组化, 11例阳性表达TTF1;10例阳性表达甲状腺球蛋白; 4例P53弥漫阳性表达, 3例局灶阳性表达; Ki67增殖指数3%~25%不等。随访期间, 2例患者分别于术后4年及术后7.5年死于肿瘤播散。  结论  PDTC是一种独特的且较少见的甲状腺恶性肿瘤, 其临床病理特点介于高分化甲状腺癌与未分化甲状腺癌之间。
  • 图  1  呈岛状结构低分化甲状腺癌, 肿瘤细胞团被含细小血管的薄层纤维组织围绕并以此为间隔形成境界清楚的岛状分布(HE, ×150)

    图  2  呈梁状结构低分化甲状腺癌, 肿瘤细胞排成索状或缎带状(HE, ×60)

    图  3  呈实性结构低分化甲状腺癌, 肿瘤细胞密集排列形成大片状实体无结构区域(HE, ×300)

    图  4  低分化甲状腺癌肿瘤组织内见较多核分裂(HE, ×300)

    图  5  低分化甲状腺癌肿瘤细胞团中央见典型的肿瘤性坏死(HE, ×150)

    图  6  具有核扭曲特征的低分化甲状腺癌, 细胞核较小且深染, 具有不规则核膜, 无毛玻璃样核及核内包涵体(HE, ×300)

    图  7  免疫组化染色示1例低分化甲状腺癌标本中约50%肿瘤细胞P53呈阳性表达, 细胞核呈中等强度着色(HE, × 300)

    图  8  免疫组化染色示1例低分化甲状腺癌标本中Ki 67增殖活性指数约为8%(HE, ×300)

    表  1  12例低分化甲状腺癌患者临床病理特点

  • [1] Sobrinho-Simoes M, Sambade C, Fonseca E, et al. Poorly differentiated carcinomas of the thyroid gland:a review of the clinicopathologic features of a series of 28 cases of a heterogeneous, clinically aggressive group of thyroid tumors[J]. Int J Surg Pathol, 2002, 10:123-131. doi:  10.1177/106689690201000205
    [2] Cabanne F, Gerard-Marchant R, Heimann R, et al. Malignant tumors of the thyroidgland. Problems of histopathologic diagnosis. Apropos of 692 lesions collected by the thyroid cancer Cooperative Group of the O. E. R. T. C[J]. Ann Anat Pathol (Paris), 1974, 19:129-148. http://europepmc.org/abstract/MED/4480015
    [3] Pilotti S, Collini P, Mariani L, et al. Insular carcinoma:a distinct de novo entity among follicular carcinomas of the thyroid gland[J]. Am J Surg Pathol, 1997, 21:1466-1473. doi:  10.1097/00000478-199712000-00009
    [4] Volante M, Collini P, Nikiforov YE, et al. Poorly differentiated thyroid carcinoma:the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach[J]. Am J Surg Pathol, 2007, 31:1256-1264. doi:  10.1097/PAS.0b013e3180309e6a
    [5] Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a highrisk group of papillary and follicular carcinomas[J]. Cancer, 1983, 52:1849-1855. doi:  10.1002/1097-0142(19831115)52:10<1849::AID-CNCR2820521015>3.0.CO;2-X
    [6] Carcangiu ML, Zampi G, Rosai J. Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans's "wuchernde Struma"[J]. Am J Surg Pathol, 1984, 8:655-668. doi:  10.1097/00000478-198409000-00005
    [7] DeLellis RA, LLoyd R, Heitz PU. WHO classification of tumors, pathology and genetics-tumors of endocrine organs[M]. Lyon, France:IARC Press, 2004.
    [8] Rufini V, Salvatori M, Fadda G, et al. Thyroid carcinomas with a variable insular component:prognostic significance of histopathologic patterns[J]. Cancer, 2007, 110:1209-1217. doi:  10.1002/cncr.22913
    [9] Dettmer M, Schmitt A, Steinert H, et al. Poorly differentiated thyroid carcinomas:how poorly differentiated is needed?[J]. Am J Surg Pathol, 2011, 35:1866-1972. doi:  10.1097/PAS.0b013e31822cf962
    [10] Asioli S, Erickson LA, Righi A, et al. Poorly differentiated carcinoma of the thyroid:validation of the Turin proposal and analysis of IMP3 expression[J]. Mod Pathol, 2010, 23:1269-1278. doi:  10.1038/modpathol.2010.117
    [11] Papotti M, Torchio B, Grassi L, et al. Poorly differentiated oxyphilic (Hurthle cell) carcinomas of the thyroid[J]. Am J Surg Pathol, 1996, 20:686-694. doi:  10.1097/00000478-199606000-00005
    [12] Volante M, Papotti M. A practical diagnostic approach to solid/trabecular nodules in the thyroid[J]. Endocr Pathol, 2008, 19:75-81. doi:  10.1007/s12022-008-9023-5
    [13] Ivanova R, Soares P, Castro P, et al. Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma:a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma[J]. Virchows Arch, 2002, 440:418-424. doi:  10.1007/s00428-001-0543-3
    [14] Dobashi Y, Sakamoto A, Sugimura H, et. al. Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma[J]. Am J Surg Pathol, 1993, 17:375-381. doi:  10.1097/00000478-199304000-00008
    [15] Pilotti S, Collini P, Del Bo R, et al. A novel panel of antibodies that segregates immunocytochemically poorly differentiated carcinoma from undifferentiated carcinoma of the thyroid gland[J]. Am J Surg Pathol, 1994, 18:1054-1064. doi:  10.1097/00000478-199410000-00009
  • 加载中
图(8) / 表(1)
计量
  • 文章访问数:  223
  • HTML全文浏览量:  94
  • PDF下载量:  3
  • 被引次数: 0
出版历程
  • 收稿日期:  2011-10-25
  • 刊出日期:  2012-01-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!